Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.

Mr. Thomas Samuel McClenahan

Executive Vice President, General Counsel & Corporate Secretary

Mr. Jon  Coleman

President of Worldwide Sales, Professional Services & Medical Affairs

Mr. Eli  Kammerman

Vice President of Business Development & Investor Relations

Mr. Tao Leopold Levy

Executive Vice President of Business Development

Mr. Joseph E. Kiani

Founder, Chief Executive Officer & Chairman

Mr. Micah  Young

Executive Vice President & Chief Financial Officer

Mr. Bilal  Muhsin

Chief Operating Officer

Mr. Paul  Hataishi

Senior Vice President & Chief Accounting Officer

Mr. Yongsam  Lee

Executive Vice President & Chief Information Officer

Dr. Steven J. Barker

Chairman of Scientific Advisory Board & Chief Science Officer

Nazwa	Kapitalizacja rynkowa
ConvaTec Group Plc	0M
Jiangsu Apon Medical Technology Co., Ltd.	0M
Ypsomed Holding AG	0M
InfuSystem Holdings, Inc.	0M
Sansure Biotech Inc.	0M
Menicon Co., Ltd.	0M
Alcon Inc.	0M
Tarsons Products Limited	0M
SDI Limited	0M
Singular Genomics Systems, Inc.	0M
Olympus Corporation	0M

Masimo Corporation

Masimo Corporation Lista konkurentów

Główni konkurenci